Slingshot members are tracking this event:
U.S. Patent Office's Patent Trial and Appeal Board (PTAB) Denies Coherus (CHRS) Petition for Inter Partes Review of AbbVie's (ABBV) U.S. Patent No. 9,114,166 for HUMIRA
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Nov 07, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords U.s. Patent Office, Trial And Appeal Board, Petition For Inter Partes Review, U.s Patent No. 9114166, Humira